A shot once day has changed her life.
“.....Small price to pay you know,” she said. “I always say you know what? I’m walking, I’m walking.”

Scientists at the UT Health Science Center have been following multiple sclerosis patients long term.

A landmark study looked at patients that have been on Copaxone for more than a decade. It showed their condition was only slightly worse than it was when they started the therapy.

Researchers also discovered attacks were reduced from twice a year to one every five years.....CLICK LINK ABOVE FOR FULL STORY